Skip to main content

Therapy and clinical trials.

Publication ,  Journal Article
Sodhi, N; Krasuski, RA
Published in: Curr Opin Lipidol
June 2013

Duke Scholars

Published In

Curr Opin Lipidol

DOI

EISSN

1473-6535

Publication Date

June 2013

Volume

24

Issue

3

Start / End Page

281 / 282

Location

England

Related Subject Headings

  • Serine Endopeptidases
  • Proprotein Convertases
  • Proprotein Convertase 9
  • Oligonucleotides
  • Niacin
  • Hyperlipoproteinemia Type II
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Humans
  • Drug Administration Schedule
  • Drug Administration Routes
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Sodhi, N., & Krasuski, R. A. (2013). Therapy and clinical trials. Curr Opin Lipidol, 24(3), 281–282. https://doi.org/10.1097/MOL.0b013e3283616351
Sodhi, Nishtha, and Richard A. Krasuski. “Therapy and clinical trials.Curr Opin Lipidol 24, no. 3 (June 2013): 281–82. https://doi.org/10.1097/MOL.0b013e3283616351.
Sodhi N, Krasuski RA. Therapy and clinical trials. Curr Opin Lipidol. 2013 Jun;24(3):281–2.
Sodhi, Nishtha, and Richard A. Krasuski. “Therapy and clinical trials.Curr Opin Lipidol, vol. 24, no. 3, June 2013, pp. 281–82. Pubmed, doi:10.1097/MOL.0b013e3283616351.
Sodhi N, Krasuski RA. Therapy and clinical trials. Curr Opin Lipidol. 2013 Jun;24(3):281–282.

Published In

Curr Opin Lipidol

DOI

EISSN

1473-6535

Publication Date

June 2013

Volume

24

Issue

3

Start / End Page

281 / 282

Location

England

Related Subject Headings

  • Serine Endopeptidases
  • Proprotein Convertases
  • Proprotein Convertase 9
  • Oligonucleotides
  • Niacin
  • Hyperlipoproteinemia Type II
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Humans
  • Drug Administration Schedule
  • Drug Administration Routes